Sterner Eric, Flanagan Natalie, Gildersleeve Jeffrey C
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute , Frederick, Maryland 21702, United States.
ACS Chem Biol. 2016 Jul 15;11(7):1773-83. doi: 10.1021/acschembio.6b00244. Epub 2016 May 25.
Antibodies are used extensively for a wide range of basic research and clinical applications. While an abundant and diverse collection of antibodies to protein antigens have been developed, good monoclonal antibodies to carbohydrates are much less common. Moreover, it can be difficult to determine if a particular antibody has the appropriate specificity, which antibody is best suited for a given application, and where to obtain that antibody. Herein, we provide an overview of the current state of the field, discuss challenges for selecting and using antiglycan antibodies, and summarize deficiencies in the existing repertoire of antiglycan antibodies. This perspective was enabled by collecting information from publications, databases, and commercial entities and assembling it into a single database, referred to as the Database of Anti-Glycan Reagents (DAGR). DAGR is a publicly available, comprehensive resource for anticarbohydrate antibodies, their applications, availability, and quality.
抗体被广泛应用于各种基础研究和临床应用中。虽然已经开发出了大量针对蛋白质抗原的多样抗体,但针对碳水化合物的优质单克隆抗体却要少见得多。此外,很难确定某一特定抗体是否具有合适的特异性、哪种抗体最适合给定的应用以及从何处获得该抗体。在此,我们概述了该领域的当前状况,讨论了选择和使用抗聚糖抗体的挑战,并总结了现有抗聚糖抗体库中的不足之处。这一观点是通过从出版物、数据库和商业实体收集信息并将其整合到一个单一数据库(称为抗聚糖试剂数据库,DAGR)中而形成的。DAGR是一个公开可用的、关于抗碳水化合物抗体及其应用、可得性和质量的综合资源。